Standout Papers
Citation Impact
Citing Papers
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
2006 StandoutScience
Molecular Aspects of Co-morbidities in COVID-19 Infection.
2020
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
2006
Actos Now for the prevention of diabetes (ACT NOW) study
2009
RELATIONSHIP BETWEEN ADIPOKINES, INFLAMMATION, AND VASCULAR REACTIVITY IN LEAN CONTROLS AND OBESE SUBJECTS WITH METABOLIC SYNDROME
2006
Hypoxia and intra-complex genetic suppressors rescue complex I mutants by a shared mechanism
2024 StandoutNobel
Prevalence of Metabolic Syndrome and Its Relation to Body Composition in a Chinese Rural Population
2006
Genetic determinants of hepatic steatosis in man
2011
Relationship of Metabolic Syndrome and Obstructive Sleep Apnea
2007
Metabolic Syndrome Among HIV-Infected Patients
2005
Child Development and Molecular Genetics: 14 Years Later
2012
The insulin resistance syndrome: implications for thrombosis and cardiovascular disease
2002
Pathogenesis of type 2 diabetes mellitus
2004
The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population
2004
Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease
2005
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Metabolic Syndrome: Treatment of Hypertensive Patients
2007
Prevalence of the metabolic syndrome among Turkish adults
2006
Inflammation and metabolic disorders
2006 StandoutNature
Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy
2006
The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects
2005
Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all‐cause mortality – results of prospective analysis for the Atherosclerosis Risk in Communities study
2007
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
2003 Standout
Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes
2008
Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome
2004
Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: Where are the insulin resistance genes?
2008
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Metabolic syndrome and target organ damage in untreated essential hypertensives
2004
Systems Biology Approach Reveals Genome to Phenome Correlation in Type 2 Diabetes
2013
Increased oxidative stress in obesity and its impact on metabolic syndrome
2004 Standout
Epidemiology of the Metabolic Syndrome
2005
Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for Type 2 diabetes
2007
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
2002 Standout
β-Cell Function in Subjects Spanning the Range from Normal Glucose Tolerance to Overt Diabetes: A New Analysis
2005
Autophagy regulates lipid metabolism
2009 StandoutNature
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
The Human Obesity Gene Map: The 2005 Update
2006
The metabolic syndrome
2010 Standout
Candidate Gene Association Study in Type 2 Diabetes Indicates a Role for Genes Involved in β-Cell Function as Well as Insulin Action
2003
Is mitochondrial dysfunction a cause of insulin resistance?
2008
A rural-urban comparison of the characteristics of the metabolic syndrome by gender in Korea: The Korean Health and Genome Study (KHGS)
2006
The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study
2007
Contribution of impaired glucose tolerance in subjects with the metabolic syndrome: Baltimore Longitudinal Study of Aging
2005
Which Features of the Metabolic Syndrome Predict the Prevalence and Clinical Outcomes of Angiographic Coronary Artery Disease?
2004
Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation
2006 Standout
Effects of Obesity Surgery on the Metabolic Syndrome
2004
Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
2003
Central Adiposity Determines Prevalence Differences of the Metabolic Syndrome
2003
Prognostic value of the metabolic syndrome in essential hypertension
2004
The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study
2003
Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada
2005
An urban–rural comparison of the prevalence of the metabolic syndrome in Eastern China
2007
Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus
2007
Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial
2007
Rare-Variant Association Analysis: Study Designs and Statistical Tests
2014
Waist Circumference, Visceral Obesity, and Cardiovascular Risk
2003
The changing landscape of atherosclerosis
2021 StandoutNature
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study
2009
The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
2004
Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view
2003
Prevalence of metabolic syndrome in an elderly Swedish population
2006
Genes and type 2 diabetes mellitus
2008
Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis
2006
Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions
2004
Association of albuminuria and the metabolic syndrome
2003
High prevalence of metabolic syndrome among young women with premature coronary artery disease
2005
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
(Mis)use of Factor Analysis in the Study of Insulin Resistance Syndrome
2004
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
2007 Standout
Molecular insights into insulin action and secretion
2002
Regulation ofFto/Ftmgene expression in mice and humans
2008
The metabolic syndrome and incidence of cardiovascular disease in non‐diabetic subjects—a population‐based study comparing three different definitions
2007
Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial
2006
Characteristics of US adults with the metabolic syndrome and therapeutic implications
2004
The metabolic syndrome
2005 Standout
The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome
2005
Epigenetic phenomena linked to diabetic complications
2010
Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects
2004
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 Standout
The immunology of atherosclerosis
2017
The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
2003
The Metabolic Syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm
2004
Candidate Genes for Type 2 Diabetes
2004
Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions
2007
The worldwide diabetes epidemic
2012
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery
2007
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
The metabolic syndrome: prevalence in worldwide populations
2004
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
2004
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Prevalence of the metabolic syndrome in Peruvian Andean hispanics: The PREVENCION study
2007
Hepatic Insulin Resistance Is Sufficient to Produce Dyslipidemia and Susceptibility to Atherosclerosis
2008
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and Objectives
2004
Obesity, Metabolic Syndrome, and Cardiovascular Disease
2004
Prevalence of the Metabolic Syndrome Among US Adults
2002 Standout
Metabolic control through the PGC-1 family of transcription coactivators
2005 Standout
Resolution of Diabetes Mellitus and Metabolic Syndrome following Roux-en-Y Gastric Bypass and a Variant of Biliopancreatic Diversion in Patients with Morbid Obesity
2007
Sedentary Lifestyle, Poor Cardiorespiratory Fitness, and the Metabolic Syndrome
2003
Cardiorespiratory Fitness Attenuates the Effects of the Metabolic Syndrome on All-Cause and Cardiovascular Disease Mortality in Men
2004
Microalbuminuria and the metabolic syndrome and its components in the Chinese population
2007
Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to Type 2 diabetes
2004
Management of metabolic syndrome: statins
2004
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
2007 Standout
Wnt signaling: relevance to β-cell biology and diabetes
2008
Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population
2006
Prevalence of the metabolic syndrome and overweight among adults in China
2005
Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents
2005
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
Single-cell transcriptomes identify human islet cell signatures and reveal cell-type–specific expression changes in type 2 diabetes
2016
Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet
2007
Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome
2003
The Human Obesity Gene Map: The 2003 Update
2004
Prevalence of Obesity and Metabolic Syndrome in Taiwan
2006
The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study
2004
Contributions of -Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose
2006
Genetics of Type 2 diabetes
2005
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
2002 Standout
The Hallmarks of Aging
2013 Standout
Genome-wide association studies for common diseases and complex traits
2005 Standout
Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents
2007
Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study
2006
Nutritional aspects in the causation and management of the metabolic syndrome
2004
Two modes of mitochondrial dysfunction lead independently to lifespan extension in Caenorhabditis elegans
2010
Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus
2005
Metabolite profiles and the risk of developing diabetes
2011 Standout
Metabolic syndrome and coronary angiographic disease progression: the Women’s Angiographic Vitamin & Estrogen trial
2003
The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes
2001
Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study)
2004
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Comprehensive Integration of Single-Cell Data
2019 Standout
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin
2006
The metabolic syndrome, diabetes, and subclinicalatherosclerosis assessed by coronary calcium
2003
High prevalence of the metabolic syndrome among Northern Jordanians
2007
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
2013 Standout
Metabolic Syndrome and CKD in a General Japanese Population: The Hisayama Study
2006
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients
2005
Obesity and cardiovascular disease
2002
The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality
2007
Inflammasomes in health and disease
2012 StandoutNature
Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis
2011
Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES‐34)
2006
Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study
2003
High prevalence of metabolic syndrome in Mexico
2004
Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women
2004
Metabolic syndrome: Definition, pathophysiology, and mechanisms
2005
Identification of Subjects with Insulin Resistance and β-Cell Dysfunction Using Alternative Definitions of the Metabolic Syndrome
2003
Prevalence and Characteristics of the Metabolic Syndrome in Women With Polycystic Ovary Syndrome
2005
Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction
2006
The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes
2006
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Effects of chromosome 17 on features of the metabolic syndrome in the Lyon hypertensive rat
2008
Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic Syndrome
2003
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults
2004 Standout
Physiological and Molecular Determinants of Insulin Action in the Baboon
2008
Genetics of the metabolic syndrome
2007
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study
2005
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
2005 Standout
Contributions of β-Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose
2006
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
2009 Standout
Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
2005
Reduction of Cardiovascular Events by Simvastatin in Nondiabetic Coronary Heart Disease Patients With and Without the Metabolic Syndrome
2004
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older
2003
Insulin Resistance as Estimated by Homeostasis Model Assessment Predicts Incident Symptomatic Cardiovascular Disease in Caucasian Subjects From the General Population
2007
Metabolic Syndrome as a Cardiovascular Risk Factor in Patients With Type 2 Diabetes
2004
Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds
2006
Prevalence of the Metabolic Syndrome and Its Components
2004
Prevalence and lifestyle determinants of the metabolic syndrome.
2005
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
2003 Standout
American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome
2003
Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult)
2001
American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome
2003
No Evidence of Association of ENPP1 Variants With Type 2 Diabetes or Obesity in a Study of 8,089 U.K. Caucasians
2006
Low Levels of Leisure-Time Physical Activity and Cardiorespiratory Fitness Predict Development of the Metabolic Syndrome
2002
Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach
2004
Measures of Insulin Resistance Add Incremental Value to the Clinical Diagnosis of Metabolic Syndrome in Association With Coronary Atherosclerosis
2004
The Metabolic Syndrome in Older Individuals: Prevalence and Prediction of Cardiovascular Events
2005
Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?
2004
Free Fatty Acids Are Independently Associated with All-Cause and Cardiovascular Mortality in Subjects with Coronary Artery Disease
2006
Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome
2005
Prevalence of a Metabolic Syndrome Phenotype in Adolescents
2003 Standout
The Prevalence of the Metabolic Syndrome in a Danish Population of Women with Previous Gestational Diabetes Mellitus Is Three-Fold Higher than in the General Population
2005
The relative contributions of insulin resistance and beta cell failure to the transition from normal to impaired glucose tolerance varies in different ethnic groups
2007
A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions
2003
Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk
2004
Genomics, Type 2 Diabetes, and Obesity
2010
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
2004
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease
2002
Can We Apply the National Cholesterol Education Program Adult Treatment Panel Definition of the Metabolic Syndrome to Asians?
2004
Prevalence and Characteristics of the Metabolic Syndrome in the San Antonio Heart and Framingham Offspring Studies
2003
The Metabolic Syndrome as Predictor of Type 2 Diabetes
2003
Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease
2004
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
2003
Is high density lipoprotein cholesterol useful in diagnosis of metabolic syndrome in native Africans with type 2 diabetes?
2005
Insulin Secretion and Action in Subjects With Impaired Fasting Glucose and Impaired Glucose Tolerance
2006
Insulin Secretion and Insulin Sensitivity Pattern Is Different in Isolated Impaired Glucose Tolerance and Impaired Fasting Glucose
2003
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
The Metabolic Syndrome, Circulating Oxidized LDL, and Risk of Myocardial Infarction in Well-Functioning Elderly People in the Health, Aging, and Body Composition Cohort
2004
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
2005
Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease in Nondiabetic American Indians
2003
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
The Metabolic Syndrome
2008 Standout
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Metabolic Syndrome Modifies the Cardiovascular Risk Associated With Angiographic Coronary Artery Disease in Women
2004
A Cluster of Three Single Nucleotide Polymorphisms in the 3′-Untranslated Region of Human Glycoprotein PC-1 Gene Stabilizes PC-1 mRNA and Is Associated With Increased PC-1 Protein Content and Insulin Resistance–Related Abnormalities
2001
Metabolic Syndrome as a Predictor of All-Cause and Cardiovascular Mortality in Type 2 Diabetes
2004
National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study
2004
Comparison of Pioglitazone and Gliclazide in Sustaining Glycemic Control Over 2 Years in Patients With Type 2 Diabetes
2005
The Prevalence of the Metabolic Syndrome in Korean Adults: Comparison of WHO and NCEP Criteria
2005
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance
2003
Prevalence of the Metabolic Syndrome in American Adolescents
2004
Insulin Resistance and Atherosclerosis
2006
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Influencia del síndrome metabólico en el riesgo cardiovascular de pacientes con diabetes tipo 2
2004
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Enantioselective Total Synthesis of Nigelladine A via Late-Stage C–H Oxidation Enabled by an Engineered P450 Enzyme
2017 StandoutNobel
Elevated Lp-PLA 2 Levels Add Prognostic Information to the Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects
2007
Prevalence of the Metabolic Syndrome Among Omani Adults
2003
Metabolic Syndrome, Obesity, and Mortality
2005
Works of Peter Almgren being referenced
Common Variants in the ENPP1 Gene Are Not Reproducibly Associated With Diabetes or Obesity
2006
Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes
2007
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
2007
The FOXC2 C‐512T Polymorphism Is Associated with Obesity and Dyslipidemia
2004
Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins
2004
A Variation in 3′ UTR of hPTP1B Increases Specific Gene Expression and Associates with Insulin Resistance
2002
Molecular correlates for maximal oxygen uptake and type 1 fibers
2008
Genetic Prediction of Future Type 2 Diabetes
2005
Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle
2007
Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets
2013
Pro-opiomelanocortin gene is associated with serum leptin levels in lean but not in obese individuals
2003
Power in the phenotypic extremes: a simulation study of power in discovery and replication of rare variants
2011
Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes
2008
A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes
2003
Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Type 2 Diabetes
2005
Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.
2000
Contribution of Insulin-Stimulated Glucose Uptake and Basal Hepatic Insulin Sensitivity to Surrogate Measures of Insulin Sensitivity
2004
Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality
2018
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
2001 Standout
Common Variants in Maturity-Onset Diabetes of the Young Genes and Future Risk of Type 2 Diabetes
2008
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA).
1999
Genetic and Nongenetic Regulation of CAPN10 mRNA Expression in Skeletal Muscle
2005
Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis.
2000
Altered DNA Methylation and Differential Expression of Genes Influencing Metabolism and Inflammation in Adipose Tissue From Subjects With Type 2 Diabetes
2014
Common Single Nucleotide Polymorphisms in TCF7L2 Are Reproducibly Associated With Type 2 Diabetes and Reduce the Insulin Response to Glucose in Nondiabetic Individuals
2006
Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins
2004
Haplotype Structure and Genotype-Phenotype Correlations of the Sulfonylurea Receptor and the Islet ATP-Sensitive Potassium Channel Gene Region
2004
High-Density Haplotype Structure and Association Testing of the Insulin-Degrading Enzyme (IDE) Gene With Type 2 Diabetes in 4,206 People
2006
High Levels of Nonesterified Fatty Acids Are Associated With Increased Familial Risk of Cardiovascular Disease
2000
Association of Common Variation in the HNF1α Gene Region With Risk of Type 2 Diabetes
2005
Association Testing of Variants in the Hepatocyte Nuclear Factor 4α Gene With Risk of Type 2 Diabetes in 7,883 People
2005